Johnson Matthey Annual Report and Accounts 2018 Strategic Report Financial review This was 4% lower than last year, reflecting more focused Introduction and disciplined investment into areas of higher potential return.
Johnson Matthey delivered results in line with expectations in Key areas of spend included next generation technologies in 2017 18.
At constant rates, sales grew 7% and underlying Clean Air, our Health API product pipeline and development of operating profit was flat.
Further aspects of the groups financial our eLNO battery material.
performance in 2017 18 are outlined below.
Foreign exchange Corporate The calculation of growth at constant rates excludes the impact In line with our guidance, corporate costs in the period were of foreign exchange movements arising from the translation of 43 million which was an increase of 11 million from overseas subsidiaries profit into sterling see note 2 on page 61.
This was driven by additional spend on central The group does not hedge the impact of translation effects on the programmes that will deliver operational excellence and income statement.
efficiency across the group, including rolling out the global The principal overseas currencies, which represented 86% procurement programme, and higher legal costs.
of non-sterling denominated underlying operating profit in the Corporate costs are expected to be higher in 2018 19 year ended 31st March 2018, were: reflecting further investment in group efficiency programmes Share of 2017 18 Average exchange rate and our IT systems.
non-sterling denominated Year ended 31st March underlying operating profit 2018 2017 % change Research and development R&D US dollar 38% 1.328 1.308 2 Euro 35% 1.134 1.191 -5 We invested 193 million on R&D in the period, including Chinese renminbi 13% 8.79 8.79 18 million of capitalised R&D, representing 5% of sales.
Anna Manz Chief Financial Officer 70 We had a good year, delivering results in line with our expectations at the start of the year In our first half, sterling decreased in value against Major impairment and restructuring costs most major currencies compared to the half year ended We have taken restructuring and impairment charges of 30th September 2016.
However, this partly reversed in the 90 million in the year, as we execute our strategy and build second half of the year especially in relation to the US dollar.
our platform for future growth.
Cash spend was 13 million This meant that overall the impact of exchange rates increased and in 2018 19 cash spend on restructuring is expected to be sales and underlying operating profit for the year as a whole by 10 million.
33 million and 9 million respectively following an 86 million The implementation of our group restructuring programme and 18 million benefit respectively in our first half.
resulted in costs of 43 million, which was below our previous If current exchange rates :$ 1.354, : 1.143, :RMB 8.62 guidance of 50 65 million.
This programme delivered are maintained throughout the year ending 31st March 2019, 12 million of cost savings in 2017 18.
We remain on track foreign currency translation will have a negative impact of to deliver around 25 million of annualised cost savings.
approximately 6 million on underlying operating profit.
A one In March 2018 we notified employees at our Health Sector cent change in the average US dollar and euro exchange rates Riverside, US facility of our intention to close the plant, as we each has an impact of approximately 2 million and 2 million continue our strategic focus on speciality, low volume, complex respectively on full year underlying operating profit and a ten APIs.
The closure of Riverside led to a charge of 36 million.
fen change in the average rate of the Chinese renminbi has an We expect the plant to cease production by the end of the first impact of approximately 1 million.
This is a key part of our plan to optimise our Health manufacturing footprint, which will deliver a small net Pgm prices benefit in 2018 19.
We have also impaired goodwill by 11 million relating to Higher average pgm prices benefited operating profit by around our Water Technologies business within New Markets reflecting 15 million in the year in Efficient Natural Resources.
lower growth assumptions for this business.
Impairment and Associated total Reconciliation of underlying operating profit to million restructuring charge cash costs operating profit Group restructuring programme 43 19 Year ended 31st March 2018 2017 Health Closure of Riverside, US 36 4 million million New Markets - Impairment of Water 11 Underlying operating profit 525 513 Total 90 23 1 Amortisation of acquired intangibles 19 20 1 Major impairment and restructuring charges 90 1 Loss on disposal of businesses 7 Loss on disposal of businesses 1 Loss on significant legal proceedings 50 On 31st January 2018, the group sold its UK automotive battery Operating profit 359 493 systems business for net proceeds of 5 million which resulted in a loss on sale of 7 million.
This is excluded from underlying 1 For further detail on these items please see notes 5 to 8 on pages 153 and 154. operating profit.
Legal settlement Finance charges As announced in February 2018, a lawsuit against a group Net finance charges in the year amounted to 38 million, company, Johnson Matthey Inc. was settled on mutually up from 31 million in 2016 17.
This was the result of higher acceptable terms with no admission of fault.
Under the precious metal funding costs.
settlement agreement, we have recognised a charge of We anticipate that net finance charges will be slightly 50 million in connection with resolution of the lawsuit.
higher in 2018 19 due to rising US interest rates and higher This charge has been excluded from underlying operating borrowing costs as we expand in China.
These will be only partly profit for the year ended 31st March 2018. offset by lower precious metal funding costs.
The five year record can be found online at: matthey.
com five-year-record 71 Other Information Accounts Governance Strategic Report Johnson Matthey Annual Report and Accounts 2018 Strategic Report Taxation 2016 17 US PRMB The effective tax rate on reported profit for the year was 6.9%, Profit growth for the period was impacted by the comparison a reduction of 9.8% from 2016 17. against a one-off gain of 17 million mainly following the The lowering of the US federal tax rate led to a revaluation implementation of an inflation cap on the US post-retirement of our US deferred tax assets and liabilities, which has resulted in medical benefit PRMB plan.
The table below shows the a 24 million non-cash benefit in the income tax expense line impact of this by sector: in the income statement for the year ended 31st March 2018.
Year ended 31st March 2017 Of this, 23 million has been excluded from the tax on million US PRMB gain underlying profit.
Tax on underlying profit was 17.7%, an increase of 0.7% Clean Air 6 from 2016 17.
Efficient Natural Resources 5 We currently expect the tax rate on underlying profit for Health 3 the year ending 31st March 2019 to be around 16%, due to New Markets 2 changes in the US tax legislation.
Corporate 1 Total 17 Our approach to tax Johnson Matthey has developed a reputation over the last The table below shows the performance excluding the impact of 200 years for integrity and our people take pride in doing the the PRMB: right thing across all aspects of our business.
These principles % change, at constant rates, underpin our approach to the management of tax.
1 Adjusted underlying operating profit growth excl.
PRMB We want to be clear and open on our approach so that our Clean Air 9 stakeholders understand it.
Today we have operations in over Efficient Natural Resources -2 30 countries and, for each of those countries, we endeavour to Health -9 pay our fair share of tax.
We follow the laws of the relevant New Markets 60 country and our group tax strategy so that we pay the correct Group 4 and appropriate amount of tax at the right time.
1 Excludes the translational FX impact on the PRMB as the impact is immaterial.
Through implementation of our tax strategy we plan to: Optimise global tax incentives and exemptions, such as those which support the research and development of our Post-employment benefits next generation of sustainable technologies.
We will only IFRS accounting basis engage in tax planning which is supported by a clear At the year end the groups net post-employment benefit commercial rationale.
position, after taking account of the bonds held to fund the UK Have clear and consistent tax policies and procedures to pension scheme deficit, was a surplus of 190 million, up from support our business strategy.
All our tax policies and a surplus of 63 million at 31st March 2017.
This increase in guidelines are managed and maintained by our the surplus mainly reflects a reduction in obligations in the UK professional tax function which is supported by external plan due to a 20 basis point increase in the real after inflation advisers.
This ensures compliance and allows us to properly discount rate caused by rising corporate bond yields and falling respond to global tax changes and developments.
The cost of providing post-employment benefits in the year Proactively identify, evaluate, manage and monitor tax risks arising from our business operations to ensure they remain was 69 million, an increase of 23 million, mainly as a result of the impact of the 17 million one-off credit in the prior year in line with the groups risk appetite, seeking external advice where necessary.
in relation to the implementation of an inflation cap in the US post-retirement medical plan.
Ensure that all tax returns are accurate, complete and are submitted in a timely manner through the activation of a Actuarial funding basis thorough tax risk compliance management process.
The UK pension scheme has a legacy defined benefit career Maintain open, positive and cooperative relationships with average section which was closed to new entrants on governments and global tax authorities.
1st October 2012 when a new defined benefit cash balance We also partake in constructive discussions on taxation policies section was opened.
that are relevant to our business.
The board approves our tax The last triennial actuarial valuation of the career average strategy each year and reviews compliance against it on a section as at 1st April 2015 revealed a deficit of 69 million, or regular basis.
That way, our strategy will encompass any learning 28 million after taking account of the future additional deficit and remain relevant and consistent with our values.
The tax funding contributions from the special purpose vehicle set up in strategy satisfies the requirements of UK Finance Act 2016.
The latest valuation update of this section as at In line with our code of ethics and commitment to doing 1st April 2017 revealed a deficit of 67 million, or 22 million the right thing, together with the requirements of Part 3 of after taking account of the special purpose vehicle.
The Criminal Finances Act 2017, we are also taking steps to put in place adequate procedures to prevent the facilitation of tax evasion.
72 During the year a pension increase exchange exercise was Improvements in efficiency and better control of working conducted whereby current retirees were invited to exchange an capital have driven a reduction in working capital days as sales inflationary-linked pension for a higher non-increasing pension.
Excluding precious metal working capital days have The last triennial actuarial valuation of the cash balance improved to 50 days from 54 days at 31st March 2017.
Average section as at 1st April 2015 revealed a surplus of 2 million working capital days excluding precious metal decreased from with the latest update as at 1st April 2017 showing a deficit 69 days to 62 days.
Our target is for working capital excluding of 3 million.
precious metal to be in the 50 to 60 day range.
The latest actuarial valuations of our two US pension schemes showed a deficit of 11 million at 30th June 2017 Dividend up from a 2 million deficit at 30th June 2016.
The board has recommended an increase of 7% in the final The deterioration in the funding position of our defined dividend to 58.25 pence per share.
Together with the interim benefit pension schemes is mainly due to a reduction in gilt dividend of 21.75 pence per share this gives a total ordinary yields and in the UK is also due to an increase in inflationary dividend for the year ended 31st March 2018 of 80.0 pence per expectations, both of which increased the value placed on share 2016 17: 75.0 pence per share.
Subject to approval by the liabilities.
shareholders, the final dividend will be paid to shareholders on 7th August 2018, with an ex dividend date of 7th June 2018.
Capital expenditure Capital expenditure was 217 million for the year ended Return on invested capital ROIC 31st March 2018, 1.4 times depreciation and amortisation ROIC declined to 16.4% from 18.2%, mainly due to an increase excluding amortisation of acquired intangibles.
In the year, in the UK pension fund asset and higher precious metal working key projects included: capital during the year.
It was also impacted by higher levels of A new Clean Air manufacturing plant in Poland to support non-current assets reflecting increased investment to drive demand from tightening legislation and the significant future growth.
share gains made in European Light Duty diesel while also enhancing our efficiency and operating flexibility.
Capital structure Continued investment in a new pgm catalyst plant in Net debt at 31st March 2018 was 679 million.
This is down Germany to meet future demand for a range of products 212 million from 30th September 2017 and is a decrease in our Catalyst Technologies business.
Net debt increases to Investment in our Health manufacturing and development 725 million when adjusted for the post-tax pension deficits.
facilities in Annan, UK and continued investment in our The groups underlying EBITDA increased to 681 million Health API product pipeline.
As a result, the groups net debt including post tax pension deficits to EBITDA was 1.1 times Upgrading our core IT business systems to drive efficiency 2016 17: 1.1 times and, whilst below our target range of across the group.
1.5 to 2.0 times, ensures we have flexibility to invest further Capital expenditure was below our previous guidance of in the future growth of the business.
285 million for the year due to more rigorous capital allocation and lower than planned spend on our Poland Clean Air plant Contingent liability caused by permitting delays.
Johnson Matthey has been informed of failures in certain Capital expenditure for 2018 19 is expected to be around engine systems for which the group supplied a particular 390 million as our investments into growth projects increases.
coated substrate as a component for emissions after-treatment.
Key projects include: The extent to which, if any, the reported failures are due to the Clean Air plants in Poland and China to meet the growing coated substrate supplied by Johnson Matthey group companies demand for our technology.
Potential solutions for the reported Investment in our eLNO demonstration and commercial engine system issues and any associated costs have not yet been plants as we commercialise our market leading product.
Johnson Matthey has not been contacted by any regulatory authority and no Johnson Matthey group Upgrading our core IT business systems.
company has been served with any contract dispute lawsuit, Depreciation and amortisation excluding amortisation of nor has any formal claim for recovery of identified costs been acquired intangibles is expected to increase by around made at this point.
Having reviewed its contractual obligations 7 million in 2018 19 primarily as we start depreciation and the information currently available to it, the group believes of our investment in upgrading our core IT systems.
that were it to be served with a contract dispute lawsuit, it would have defensible warranty positions in respect of its supplies of Free cash flow and working capital coated substrate for the after-treatment systems in the affected engines.
If required, it will vigorously assert its available Free cash flow was 136 million.
Within this, working capital contractual protections and defences.
The outcome of any outflows of 158 million were impacted by a precious metal discussions is not certain, nor is the group able to make a reliable outflow of 84 million driven by higher precious metal prices estimate of the possible financial impact at this stage, if any.
and volumes, and non-precious metal related outflows of 64 million.
73 Other Information Accounts Governance Strategic Report
